Resultados globales: 8 registros encontrados en 0.02 segundos.
Artículos, Encontrados 7 registros
Documentos de investigación, Encontrados 1 registros
Artículos Encontrados 7 registros  
1.
9 p, 2.5 MB Collaborative model for diagnosis and treatment of very rare diseases : experience in Spain with thymidine kinase 2 deficiency / Domínguez-González, C (Instituto de Salud Carlos III) ; Madruga-Garrido, Marcos (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Hirano, Michio (Columbia University Medical Center) ; Martí, Itxaso (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Martín, Miguel A. (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Munell Casadesus, Francina (Hospital Universitari Vall d'Hebron) ; Nascimento, Andrés (Institut de Recerca Sant Joan de Déu) ; Olive, Montse (Institut d'Investigació Biomèdica Sant Pau) ; Quan, Joanne (Zogenix. Inc.) ; Sardina, Maria Dolores (Complejo Hospitalario Universitario de Badajoz) ; Martí, Ramon A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Paradas, Carmen (Instituto de Salud Carlos III) ; Universitat Autònoma de Barcelona
Background: Mitochondrial diseases are difficult to diagnose and treat. Recent advances in genetic diagnostics and more effective treatment options can improve patient diagnosis and prognosis, but patients with mitochondrial disease typically experience delays in diagnosis and treatment. [...]
2021 - 10.1186/s13023-021-02030-w
Orphanet Journal of Rare Diseases, Vol. 16 Núm. 1 (december 2021) , p. 407  
2.
10 p, 2.1 MB Late-onset thymidine kinase 2 deficiency : a review of 18 cases / Domínguez-González, C (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Hernández-Laín, Aurelio (Hospital Universitario 12 de Octubre (Madrid)) ; Rivas, Eloy (Universidad de Sevilla) ; Hernández Voth, Ana (Hospital Universitario 12 de Octubre (Madrid)) ; Sayas Catalán, Javier (Hospital Universitario 12 de Octubre (Madrid)) ; Fernández-Torrón, Roberto (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Fuiza-Luces, Carmen (Hospital Universitario 12 de Octubre (Madrid)) ; García García, Jorge (Complejo Hospitalario Universitario de Albacete) ; Morís, Germán (Hospital Universitario Central de Asturias) ; Olive, Montse (Institut d'Investigació Biomèdica de Bellvitge) ; Miralles, Frances (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Caballero Sahelices, Concesa (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; Méndez-Ferrer, Bosco (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Martí, Ramon A. (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Garcia-Arumi, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Badosa, María Carmen (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Esteban, Jesús (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Jiménez Mallebrera, Cecilia (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Encinar, Alberto Blazquez (Hospital Universitario 12 de Octubre (Madrid)) ; Arenas, Joaquín (Hospital Universitario 12 de Octubre (Madrid)) ; Hirano, Michio (Columbia University Medical Center, New York) ; Martin, Miguel Ángel (Hospital Universitario 12 de Octubre (Madrid)) ; Paradas, Carmen (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Universitat Autònoma de Barcelona
TK2 gene encodes for mitochondrial thymidine kinase, which phosphorylates the pyrimidine nucleosides thymidine and deoxycytidine. Recessive mutations in the TK2 gene are responsible for the 'myopathic form' of the mitochondrial depletion/multiple deletions syndrome, with a wide spectrum of severity. [...]
2019 - 10.1186/s13023-019-1071-z
Orphanet Journal of Rare Diseases, Vol. 14 (may 2019)  
3.
13 p, 1.8 MB Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy / Domínguez-González, Cristina (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Badosa, Carmen (Institut de Recerca Sant Joan de Déu) ; Madruga-Garrido, Marcos (Universidad de Sevilla) ; Martí, Itxaso (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Paradas, Carmen (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Ortez González, Carlos Ignacio (Institut de Recerca Sant Joan de Déu) ; Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Berardo, Andres (Columbia University Medical Center) ; Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Trifunov, Selena (Institut de Recerca Sant Joan de Déu) ; Cuadras, Daniel (Fundació Privada per a la Recerca i Docència Sant Joan de Déu) ; Kalko, Susana G. (Moebius Research Ltd, London, UK) ; Blázquez-Bermejo, Cora (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cámara, Yolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martí, Ramon A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Mavillard, Fabiola (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Martin, Miguel A. (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Montoya, Julio (Universidad de Zaragoza) ; Ruiz-Pesini, Eduardo (Universidad de Zaragoza) ; Villarroya, Joan (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ; Montero, Raquel (Institut de Recerca Sant Joan de Déu) ; Villarroya, Francesc (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ; Artuch, R. (Institut de Recerca Sant Joan de Déu) ; Hirano, Michio (Columbia University Medical Center) ; Nascimento, Andrés (Institut de Recerca Sant Joan de Déu) ; Jiménez Mallebrera, Cecilia (Universitat de Barcelona) ; Universitat Autònoma de Barcelona
GDF-15 is a biomarker for mitochondrial diseases. We investigated the application of GDF-15 as biomarker of disease severity and response to deoxynucleoside treatment in patients with thymidine kinase 2 (TK2) deficiency and compared it to FGF-21. [...]
2020 - 10.1038/s41598-020-66940-8
Scientific reports, Vol. 10 (june 2020)  
4.
12 p, 2.8 MB Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides / Vila-Julià, Ferran (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cabrera-Pérez, Raquel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cámara, Yolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Molina-Berenguer, Miguel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lope-Piedrafita, Silvia (Universitat Autònoma de Barcelona. Servei de Ressonància Magnètica Nuclear) ; Hirano, Michio (Department of Neurology, H. Houston Merritt Neuromuscular Research Center, Columbia University Irving Medical Center) ; Mingozzi, Federico (Spark Therapeutics) ; Torres-Torronteras, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martí, Ramon A. (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Preclinical studies have shown that gene therapy is a feasible approach to treat mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). However, the genetic murine model of the disease (Tymp/Upp1 double knockout, dKO) has a limited functional phenotype beyond the metabolic imbalances, and so the studies showing efficacy of gene therapy have relied almost exclusively on demonstrating correction of the biochemical phenotype. [...]
2020 - 10.1016/j.ebiom.2020.103133
EBioMedicine, Vol. 62 (november 2020)  
5.
9 p, 359.6 KB The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations / Rodríguez Cruz, Pedro M. (John Radcliffe Hospital (Oxford, Regne Unit)) ; Cossins, Judith (Neurosciences Group. Nuffield Department of Clinical Neurosciences. Weatherall Institute of Molecular Medicine. University of Oxford) ; De Paula Estephan, Eduardo (Departamento de Neurologia. Faculdade de Medicina. Universidade de São Paulo (FMUSP)) ; Munell Casadesus, Francina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Selby, KKathryn (University of British Columbia) ; Hirano, Michio (Department of Neurology. H. Houston Merritt Neuromuscular Research Center. Columbia University Medical Center) ; Maroofin, Reza (Molecular and Clinical Sciences Institute. St. George's. University of London) ; Mehrjardi, Mohammad Yahya Vahid (Medical Genetics Research Centre. Shahid Sadoughi University of Medical Sciences) ; Chow, Gabriel (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Carr, Aislin (MRC Centre for Neuromuscular Diseases. National Hospital for Neurology and Neurosurgery) ; Manzur, Adnan (Dubowitz Neuromuscular Centre. MRC Centre for Neuromuscular Diseases. UCL Great Ormond Street Institute of Child Health) ; Robb, Stephanie (Dubowitz Neuromuscular Centre. MRC Centre for Neuromuscular Diseases. UCL Great Ormond Street Institute of Child Health) ; Munot, Pinki (Dubowitz Neuromuscular Centre. MRC Centre for Neuromuscular Diseases. UCL Great Ormond Street Institute of Child Health) ; Wei Liu, Wei (Neurosciences Group. Nuffield Department of Clinical Neurosciences. Weatherall Institute of Molecular Medicine. University of Oxford) ; Banka, Siddharth (Manchester Centre for Genomic Medicine. St Mary's Hospital. Manchester University NHS Foundation Trust. Health Innovation Manchester) ; Fraser, Harry (Manchester Centre for Genomic Medicine. St Mary's Hospital. Manchester University NHS Foundation Trust. Health Innovation Manchester) ; De Goede, Christian (Department of Paediatric Neurology. Royal Preston Hospital) ; Zanoteli, Edmar (Departamento de Neurologia. Faculdade de Medicina. Universidade de São Paulo (FMUSP)) ; Conti Reed, Umbertina (Departamento de Neurologia. Faculdade de Medicina. Universidade de São Paulo (FMUSP)) ; Sage, Abigail (Department of Neurology. H. Houston Merritt Neuromuscular Research Center. Columbia University Medical Center) ; Gratacòs-Viñola, Margarida (Hospital Universitari Vall d'Hebron) ; Macaya Ruiz, Alfons (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Dusl, Marina (Friedrich-Baur-Institute. Department of Neurology. University Hospital LMU Munich) ; Senderek, Jan (Friedrich-Baur-Institute. Department of Neurology. University Hospital LMU Munich) ; Töpf, Ana (Institute of Genetic Medicine) ; Hofer, Monika (John Radcliffe Hospital (Oxford, Regne Unit)) ; Knight, Ravi (John Radcliffe Hospital (Oxford, Regne Unit)) ; Ramdas, Sithara (Department of Paediatric Neurology. John Radcliffe Hospital NHS Foundation Trust) ; Jayawant, Sandeep (Department of Paediatric Neurology. John Radcliffe Hospital NHS Foundation Trust) ; Lochmüller, Hans (Division of Neurology. Department of Medicine. Ottawa Hospital) ; Palace, Jacqueline (John Radcliffe Hospital (Oxford, Regne Unit)) ; Beeson, David (Neurosciences Group. Nuffield Department of Clinical Neurosciences. Weatherall Institute of Molecular Medicine. University of Oxford) ; Universitat Autònoma de Barcelona
Next generation sequencing techniques were recently used to show mutations in COL13A1 cause synaptic basal lamina-associated congenital myasthenic syndrome type 19. Animal studies showed COL13A1, a synaptic extracellular-matrix protein, is involved in the formation and maintenance of the neuromuscular synapse that appears independent of the Agrin-LRP4-MuSK-DOK7 acetylcholine receptor clustering pathway. [...]
2019 - 10.1093/brain/awz107
Brain, Vol. 142 Núm. 6 (january 2019) , p. 1547-1560  
6.
21 p, 4.8 MB A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss / Servián Morilla, Emilia (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Takeuchi, Hideyuki (The University of Georgia) ; Lee, Tom V. (Baylor College of Medicine) ; Clarimón, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Mavillard, Fabiola (Universidad de Sevilla) ; Area Gómez, Estela (Columbia University Medical Center) ; Rivas, Eloy (Universidad de Sevilla) ; Nieto González, José L. (Universidad de Sevilla) ; Rivero, María C. (Universidad de Sevilla) ; Cabrera-Serrano, Macarena (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Gómez Sánchez, Leonardo (Universidad de Sevilla) ; Martínez López, José A. (Universidad de Sevilla) ; Estrada, Beatriz (Universidad Pablo de Olavide) ; Márquez, Celedonio (Universidad de Sevilla) ; Morgado, Yolanda (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Suarez-Calvet, Xavier (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Pita, Guillermo (Centro Nacional de Investigaciones Oncológicas) ; Bigot, Anne (Sorbonne Universités) ; Gallardo, Eduard (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Fernandez-Chacon, Rafael (Universidad de Sevilla) ; Hirano, Michio (Columbia University Medical Center) ; Haltiwanger, Robert S. (The University of Georgia) ; Jafar-Nejad, Hamed (Baylor College of Medicine) ; Paradas, Carmen (Columbia University Medical Center) ; Universitat Autònoma de Barcelona
Skeletal muscle regeneration by muscle satellite cells is a physiological mechanism activated upon muscle damage and regulated by Notch signaling. In a family with autosomal recessive limb-girdle muscular dystrophy, we identified a missense mutation in 1 (protein O -glucosyltransferase 1), an enzyme involved in Notch posttranslational modification and function. [...]
2016 - 10.15252/emmm.201505815
EMBO Molecular Medicine, Vol. 8, Issue 11 (November 2016) , p. 1289-1309  
7.
23 p, 4.0 MB MPV17 Loss Causes Deoxynucleotide Insufficiency and Slow DNA Replication in Mitochondria / Dalla Rosa, Ilaria (MRC Mill Hill Laboratory, London, United Kingdom) ; Cámara, Yolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Durigon, Romina (MRC Mill Hill Laboratory) ; Moss, Chloe F. (MRC Mill Hill Laboratory) ; Vidoni, Sara (MRC Mitochondrial Biology Unit, Wellcome Trust-MRC Building) ; Akman, Gokhan (MRC Mill Hill Laboratory) ; Hunt, Lilian (MRC Mill Hill Laboratory) ; Johnson, Mark A. (MRC Mitochondrial Biology Unit, Wellcome Trust-MRC Building) ; Grocott, Sarah (Mitochondrial Genetics Group, Nuffield Department of Obstetrics and Gynaecology, Women's Centre, The John Radcliffe Hospital, Oxford, United Kingdom) ; Wang, Liya (Department of Anatomy, Physiology and Biochemistry, The Swedish University of Agricultural Sciences, Biomedical Center) ; Thorburn, David R. (Murdoch Childrens Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital) ; Hirano, Michio (Department of Neurology, Columbia University Medical Center, New York, New York, United States of America) ; Poulton, Joanna (Mitochondrial Genetics Group, Nuffield Department of Obstetrics and Gynaecology, Women's Centre, The John Radcliffe Hospital) ; Taylor, Robert W. (Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, The Medical School, Newcastle upon Tyne) ; Elgar, Greg (MRC Mill Hill Laboratory) ; Martí, Ramon A. (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Voshol, Peter (Institute of Metabolic Science, University of Cambridge) ; Holt, Ian J. (MRC Mill Hill Laboratory, London) ; Spinazzola, Antonella (MRC Mill Hill Laboratory) ; Universitat Autònoma de Barcelona
MPV17 is a mitochondrial inner membrane protein whose dysfunction causes mitochondrial DNA abnormalities and disease by an unknown mechanism. Perturbations of deoxynucleoside triphosphate (dNTP) pools are a recognized cause of mitochondrial genomic instability; therefore, we determined DNA copy number and dNTP levels in mitochondria of two models of MPV17 deficiency. [...]
2016 - 10.1371/journal.pgen.1005779
PLoS Genetics, Vol. 12 (january 2016)  

Documentos de investigación Encontrados 1 registros  
1.
18 p, 335.9 KB Anàlisi genètico-molecular d'una nova forma de distròfia muscular de maluc autosòmica dominant en un extens pedigrí / Palenzuela, Lluís ; Andreu Périz, Antoni Lluís, dir. (Hospital Universitari Vall d'Hebron) ; Hirano, Michio, dir.
S'ha abordat l'estudi genètico-molecular d'una extensa família espanyola afectada per una nova forma de distròfia muscular de maluc (Limb-girdle muscle dystrophy, LGMD) amb herència autosòmica dominant. [...]
It has been performed the genetic and molecular analysis of a large Spanish family affected by a new limb-girdle muscle dystrophy form (LGMD) with an autosomal dominant inheritance trait. Once described the clinical features of the disease we compared them with the 5 other autosomal dominant LGMD previously described. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2002
11 documentos

Vea también: autores con nombres similares
1 Hirano, Michio,
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.